[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR001768A1 - Derivados de ciclolignano utiles como antineoplasicos composiciones farmaceuticas que los contienen y proceso para preparar dichos derivados - Google Patents

Derivados de ciclolignano utiles como antineoplasicos composiciones farmaceuticas que los contienen y proceso para preparar dichos derivados

Info

Publication number
AR001768A1
AR001768A1 AR33423395A AR33423395A AR001768A1 AR 001768 A1 AR001768 A1 AR 001768A1 AR 33423395 A AR33423395 A AR 33423395A AR 33423395 A AR33423395 A AR 33423395A AR 001768 A1 AR001768 A1 AR 001768A1
Authority
AR
Argentina
Prior art keywords
alkyl
derivatives
group
cyclolignan
preparing
Prior art date
Application number
AR33423395A
Other languages
English (en)
Original Assignee
Univ Salamanca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Salamanca filed Critical Univ Salamanca
Publication of AR001768A1 publication Critical patent/AR001768A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se trata de compuestos de ciclolignano útil como antineoplásicos, caracterizados porque tienen fórmula (I), en la que: Ar es un 3,4,5-trialcoxifenilo o 4-hidroxi-3,5-dialcoxi(C1-C6)fenilo; X es un átomo de oxígeno ,azufre o nitrógeno,un gru pometino=CH-o un grupo alquil(C1-C6)=C(alquilo(C1C6), Y es un átomo de hidrógeno o un grupo alquilo (C1-C6), alquenilo (C3-C6) (poli)haloalquilo(C1C6), arilo, hidroxi, alcoxi (C1-C6), amino, monoalquil(C1-C6)amino; dialquil(C1-C6)amino; (poli)haloalquil (C1-C6)amino; arilamino, acilo(C1-C30) o acetamido, o el grupo Y se encuentra ausente; Z es un grupoalquilo (C1-C6), hidroxialquilo (C1-C6), acilo (C1-C30) carboxi, alcoxi(C1-C6)carbonilo o ariloxicarbonilo; y las líneas punteadasindican un enlace doble ubicada en la posición 7-8 u 8-8.
AR33423395A 1994-11-14 1995-11-14 Derivados de ciclolignano utiles como antineoplasicos composiciones farmaceuticas que los contienen y proceso para preparar dichos derivados AR001768A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9422946A GB9422946D0 (en) 1994-11-14 1994-11-14 Antineoplastic cyclolignan derivatives

Publications (1)

Publication Number Publication Date
AR001768A1 true AR001768A1 (es) 1997-12-10

Family

ID=10764357

Family Applications (1)

Application Number Title Priority Date Filing Date
AR33423395A AR001768A1 (es) 1994-11-14 1995-11-14 Derivados de ciclolignano utiles como antineoplasicos composiciones farmaceuticas que los contienen y proceso para preparar dichos derivados

Country Status (13)

Country Link
US (2) US5747529A (es)
EP (1) EP0711767B1 (es)
JP (1) JPH08269041A (es)
AR (1) AR001768A1 (es)
AU (1) AU3784595A (es)
BR (1) BR9505177A (es)
CA (1) CA2162761C (es)
DE (1) DE69511993T2 (es)
ES (1) ES2139850T3 (es)
GB (1) GB9422946D0 (es)
IL (1) IL115981A (es)
NZ (1) NZ280456A (es)
ZA (1) ZA959662B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5578099A (en) 1998-08-25 2000-03-14 National Taiwan University Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin andits analogs
US20150150455A9 (en) * 2002-07-03 2015-06-04 Epley Research, Llc Stimulus-evoked vestibular evaluation system, method and apparatus
US20100268125A9 (en) * 2002-07-03 2010-10-21 Epley Research, L.L.C. Head-stabilized medical apparatus, system and methodology
US7892180B2 (en) * 2002-11-18 2011-02-22 Epley Research Llc Head-stabilized medical apparatus, system and methodology
US7351246B2 (en) * 2004-01-20 2008-04-01 Epley John M Minimally invasive, sustained, intra-tympanic drug delivery system
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6613143A (es) * 1965-09-21 1967-03-22
US5011948A (en) * 1985-04-12 1991-04-30 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
US4734512A (en) * 1985-12-05 1988-03-29 Bristol-Myers Company Intermediates for the production of podophyllotoxin and related compounds and processes for the preparation and use thereof

Also Published As

Publication number Publication date
EP0711767A1 (en) 1996-05-15
CA2162761A1 (en) 1996-05-15
DE69511993D1 (de) 1999-10-14
NZ280456A (en) 1998-09-24
US5834507A (en) 1998-11-10
EP0711767B1 (en) 1999-09-08
IL115981A0 (en) 1996-01-31
JPH08269041A (ja) 1996-10-15
IL115981A (en) 1999-10-28
BR9505177A (pt) 1997-10-28
ZA959662B (en) 1996-05-29
CA2162761C (en) 2005-08-23
US5747529A (en) 1998-05-05
GB9422946D0 (en) 1995-01-04
ES2139850T3 (es) 2000-02-16
AU3784595A (en) 1996-05-23
DE69511993T2 (de) 2000-05-04

Similar Documents

Publication Publication Date Title
TWI262805B (en) Pharmaceutical composition for treating or inhibiting colonic polyps
DK1076663T3 (da) Funktionaliserede alkyl- og alkenylsidekædederivater af glycinamider som farnesyltransferaseinhibitorer
ES2191356T3 (es) Compuestos heterociclicos para la inhibicion de la secrecion de acidos gastricos, procedimientos para su preparacion y composiciones farmaceuticas de ellos.
ES2114645T3 (es) Utilizacion de un fosfato de alfa-tocoferol, o de uno de sus derivados para la preparacion de una composicion cosmetica, dermatologica o farmaceutica, de actividad anti-radicalar; composicion asi obtenida.
TR199800990T2 (xx) Metaloproteinaz inhibit�rleri, bunlar� i�eren farmas�tik bile�imler, bunlar�n farmas�tik kullan�mlar� ve bunlar�n �retiminde kullan�labilecek y�ntemler ve ara �r�nler.
ZA919181B (en) Oxazolopyridine derivatives,processes for preparing these and pharmaceutical compositions containing them
ATE159950T1 (de) N-alkyl-2-substituierte atp-analoge
AR029634A1 (es) Compuestos derivados heterociclicos utiles como agentes anticancerosos, composicion farmaceutica y procedimiento de tratamiento
AR026748A1 (es) Un compuesto inhibidor de caspasas, una composicion farmaceutica que lo comprende, un metodo para la sintesis del mismo y un compuesto intermediario paradicha sintesis
AR020032A1 (es) Derivados de 1,3 -metil eritromicina.
RS49906B (sr) Benzociklohepteni, postupak za njihovo dobijanje, farmaceutski preparati koji ove sadrže kao i njihova primena za izradu lekova
ATE209034T1 (de) Taxolderivate
ATE297904T1 (de) Halo-alkoxycarbonylverbindungen
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
ATE233764T1 (de) Tricyclische triazolobenzazepinderivate, verfahren zu ihrer herstellung und antiallergische mittel
AR026267A1 (es) Agentes heterociclicos citotoxicos.
AR001768A1 (es) Derivados de ciclolignano utiles como antineoplasicos composiciones farmaceuticas que los contienen y proceso para preparar dichos derivados
DK0499544T3 (da) Anvendelse af tetrahydrothienopyridinderivater som inhibitorer af angiogenese
ATE155140T1 (de) 3-deoxyoligosacchariden, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69933885D1 (de) Triphenylbutenderivate zur behandlung von neurologischen störungen
AR003130A1 (es) Compuestos antimicrobianos de trifenilalquilo, metodo para la preparacion de los mismos y composicion farmaceutica que los contiene.
DE60043293D1 (de) VAKUOLAR-TYP (H+)-ATPase-HEMMENDE VERBINDUNGEN, ZUSAMMENSETZUNGEN UND DEREN VERWENDUNGEN
ZA944727B (en) Phosphonic acid compounds processes for preparing them and pharmaceutical compositions containing them
CO4750819A1 (es) Procedimientos para inhibir el inhibidor del activador del plasminogeno 1
DK0486385T3 (da) Imidazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem